AMENDED AND RESTATED LICENSE & COMMERCIALIZATION AGREEMENT by and between LEE’S PHARMACEUTICAL holdings Limited, Zhaoke Pharmaceutical (HEFEI) Co. Ltd., lee’s pharmaceutical ( guangZhou ) limited AND PLX PHARMA llc AMENDED AND RESTATED LICENSE &...License & Commercialization Agreement • January 5th, 2016 • PLX Pharma Inc. • Pharmaceutical preparations • Hong Kong
Contract Type FiledJanuary 5th, 2016 Company Industry JurisdictionThis Amended and Restated License & Commercialization Agreement (“Agreement”) is entered into by and between PLx Pharma LLC, a Texas limited liability company having a principal place of business located at 8285 El Rio, Suite 130, Houston, Texas 77054 (“PLx”) and LEE’S PHARMACEUTICAL Holdings Limited (“Lee’s”), Zhaoke Pharmaceutical (HEFEI) Co. Ltd. (“Zhaoke”), and LEE’S PHARMACEUTICAL (GUANGzHOU ) LIMITED (“Guangzhou” ) (Guangzhou and, collectively, together with Lee’s and Zhaoke, “Licensee”). PLx and Licensee (and, respectively, Lee’s, Zhaoke and Guangzhou) may individually be referred to as Party or collectively as Parties.